Riskpilot← Back to searchSign inGet full accessORTHO VITA AS
ASActiveOrg 998720621Hoffsjef Løvenskiolds Vei 15, 0382 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20120 employees
Revenue 2024
NOK 824K
+67% vs 2023
EBITDA margin
32.6%
+315% vs 2023
Equity ratio
82.7%
Financial strength
Net profit 2024
NOK 270K
+320% vs 2023
| Revenue | NOK 824K | +67% |
| EBITDA | NOK 269K | +315% |
| Net profit | NOK 270K | +320% |
| Total assets | NOK 365K | +175% |
| Equity | NOK 302K | +864% |
| Employees | 0 | — |
Legal name
ORTHO VITA AS
Org number
998720621
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. august 2012
Share capital
NOK 530 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av medisinske produkter og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Hoffsjef Løvenskiolds Vei 15, 0382 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 786 | 787 | 338 | 493 | 824 |
| Staff expenses | −4 | −8 | −2 | −17 | −10 |
| EBITDA | 66 | −2 | −105 | −125 | 269 |
| Depreciation & amort. | −15 | −15 | −10 | −0 | −0 |
| EBIT | 51 | −17 | −115 | −125 | 269 |
| Net financials | 0 | −2 | −0 | 2 | 1 |
| Profit before tax | 51 | −18 | −115 | −123 | 270 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 51 | −18 | −115 | −123 | 270 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 578 | 444 | 282 | 133 | 365 |
| Equity | 288 | 270 | 154 | 31 | 302 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 290 | 175 | 127 | 101 | 63 |
| Total debt | 290 | 175 | 127 | 101 | 63 |
EBITDA margin
32.6%
This company
15.8%
Market median
+106% vs market
20202024
Equity ratio
82.7%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
89.6%
This company
18.4%
Market median
+387% vs market
20202024
Net profit margin
32.8%
This company
8.1%
Market median
+305% vs market
20202024
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AV Contact Person | Contact Person | 2012 |
| Former (1) | ||
SV Deputy Member | Deputy Member | 2012 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORTHO VITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simen Verpe Eriksen | Deputy Member | 0 companies |
| Anna Verpe Eriksen | Contact Person | 0 companies |
| Stein Inge Eriksen | Chairman | 0 companies |